Tuesday, July 3, 2012
GlaxoSmithKline pleads guilty in $3B US drug fraud case - CBC.ca
CBC.caGlaxoSmithKline pleads guilty in $ 3B US drug fraud caseCBC.caDrug maker GlaxoSmithKline (GSK) has agreed to pay $ 3 billion US in criminal and civil fines and plead guilty to misdemeanour criminal charges related to the sale and marketing of its antidepressants Paxil and Wellbutrin and the diabetes drug Avandia ...GlaxoSmithKline Agrees to $ 3 Billion Settlement with Justice DepartmentOzarksFirst.comDr. Drew paid to talk up meds? Feds claim YES!New York Daily NewsHealth Highlights:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment